Table 3.

Clinical signs and C. albicans density in the oral cavities of patients with APECED

Patient	OCa	Other CMCb	Data from 2005 (rinse)c
			Clinical assessment 1			Clinical assessment 2			Clinical assessment 3
			Clinical signs of OC	CFU/ml	No. stored	Clinical signs of OC	CFU/ml	No. stored	Clinical signs of OC	CFU/ml	No. stored
1	Y	Y	PC, EC, AC	>10,000	6	PC, EC, AC	>10,000	3	PC, EC, AC	380	3
2	N	Y	PC, EC, AC	940	4
3	Y	Y	PC, EC, AC	80	3
4	Y	Y	PC, EC	500	2	PC	5,920	3	PC	1,700	1
5	Y	Y	PC, EC, AC	>10,000	10	N	130	1	EC, AC	1,680	2
6	Y	N	EC	70	3	PC, EC	1,300	5	EC, AC	510	3
7	Y	Y	N	0	0	N	0	0	N	0	0
8	Y	Y	N	0	0	N	0	0	N	0	0
9	Y	Y	EC, AC	380	5
10	N	Y	N	0	0	N	2	2	N	500	1
11	Y	Y	PC, EC, AC	1280	9	N	120	1	N	0	0
12	Y	Y	N	140	10	N	50	3	PC	>10,000	3
13	Y	Y	EC	80	2	EC	0	0	N	0	0
14	Y	Y	EC	>10,000	2
15	Y	Y	N	0	0
16	Y	Y	PC, EC, AC	1840	9	PC, EC, AC	1,300	4	PC, EC, AC	360	2

^aY, yes; N, no. Whether the patient had a history of oral candidiasis (OC) is indicated.

^bY, yes; N, no. Whether the patient had a history of chronic mucocutaneous candidiasis (CMC) apart from OC is indicated.

^cPatients provided an oral rinse sample from at least one clinical assessment in 2005. “Clinical signs of OC” refers to clinical signs at the time of assessment. The CFU/ml data refer to the Candida density recovered from oral rinse samples. No. stored, the number of isolates stored from each visit for further analysis. Blank fields indicate clinical assessments that were not attended by patients. PC, pseudomembraneous candidiasis; EC, erythematous candidiasis; AC, angular cheilitis.